Inclusion Criteria:

Physicians:

- who treat patients with DLBCL and HD as per self report

Patients of Physicians:

- have a new diagnosis of Hodgkin's or Diffuse Large B-cell Lymphoma as per pathology
report or physician assessment in medical record and/or clinical judgment of the
treating physician treated with curative intent.

For part 1 - have scans indicating remission and completing planned chemotherapy and/or
radiation therapy. The treating physician will determine that clinical remission has been
achieved based on their best judgment.

For part 2 (longitudinal phase): - have new scans indicating remission and completing
planned chemotherapy and/or radiation therapy. The treating physician will determine that
clinical remission has been achieved based on their best judgment.

- be at least 18 years old

- speak English well enough, in the judgment of the consenting professional, to be able
to understand all aspects of the study, provide informed consent, and be able to
complete all study measures.

Exclusion Criteria:

Physicians:

- who do not have adequate patients in their clinical practice to meet the 8 patient
enrollment requirement for patients with either DLBCL or HD as per self report

Patients of Physicians:

- show evidence of cognitive impairment severe enough to preclude giving permission to
the study staff, or completing the survey instruments of the study.

- as per physician judgment, patient's prognosis and/or co-morbidities make them
inappropriate for participation in a survivorship study.

For Part 2 ONLY (longitudinal phase):

- those who consented to part 1, consult recording, of the study.